HOME >> BIOLOGY >> NEWS
Gene may produce drought-resistant plants

WEST LAFAYETTE, Ind. - The identification and duplication of a gene that controls production of plants' outermost protective coating may allow Purdue University researchers to create crops with increased drought resistance.

Scientists cloned the gene WAX2 after they discovered a fast-wilting mutant of Arabidopsis, a commonly used experimental plant. The gene is directly associated with the synthesis of the protective layer of plants, called the cuticle, and its contained waxes, according to the study published in the May issue of The Plant Cell.

The difference in the mutant Arabidopsis when compared to a wild-type, or normal, plant is the plants' ability to retain water. This is apparently because the mutation, called wax2, has a different cuticle structure than found in a plant that has the normal gene, WAX2.

"If we can alter the expression of the WAX2 gene, we might be able to produce a cuticle that is thicker or more rigid so that it's less permeable to water loss," said Matt Jenks, associate professor of horticulture and landscape architecture.

Manipulating what the gene does or when it is turned on could result in plants better able to survive in arid conditions.

Jenks and his research team isolated more than 20 mutant Arabidopsis plants that showed alterations in the amount of wax they produced. Of these, only a few lost water more quickly than the wild type.

"The mutant wax2 was the most drought susceptible," Jenks said. "Unlike previously described wax mutants, removal of the WAX2 gene product causes dramatic alteration in the cuticle membrane, and the plant no longer is able to prevent water loss."

Jenks said he believes that when the cuticle membrane structure is changed because of the wax2 malfunction of the WAX2 gene, the protective wax within the cuticle membrane is displaced, affecting transpiration. Transpiration is how plants emit waste matter though their leaf surfaces.

"It's likely t
'"/>

Contact: Susan A. Steeves
ssteeves@aes.purdue.edu
765-496-7481
Purdue University
21-May-2003


Page: 1 2

Related biology news :

1. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
2. Spontaneous mutation produces new MAO A/B knockout mouse
3. Scientists reinvent DNA as template to produce organic molecules
4. Therapeutic cloning no longer a dream, says scientist who produced first cloned embryonic stem cell
5. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
6. Biologists discover nerve activity, not just genetics controls kinds of neurotransmitters produced
7. Tigecycline - Candidate antibiotic produces 74 percent cure rate in cSSSI patients
8. First genetic comparison of purebred domestic dogs produces surprises
9. Biological computer diagnoses cancer and produces drug in a test tube
10. High-fat fast-food breakfast produces rush of inflammatory factors into blood stream, UB study finds
11. Oil exploitation in Ecuadors Amazon basin produces a public health emergency

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene may produce drought resistant plants

(Date:3/20/2015)... 20, 2015 Research and Markets ... the "India Sensors Market Forecast and Opportunities ... The sensor market is projected to grow at ... Consumer electronics, automotive, industrial and healthcare sectors are ... country. In addition, adoption of MEMS technology in ...
(Date:3/20/2015)... Conn. , March 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... smart wallet is one of the products featured in ... March 20th at 11:00 PM EST on the DIY ... to Las Vegas , site of ...
(Date:3/19/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces its biometric payment technology, the Wocket® smart ... week on Washington DC,s Fox 5 ... "The Next Great Thing", host Laura Evans calls ... ,a really big breakthrough in mobile payment.,  ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
(Date:4/16/2015)... MOSCOW , April 16, 2015 /PRNewswire/ ... (ChemRar), the Russian pharmaceutical investment and R&D ... announced collaboration for research, development and commercialization ... with the intention to stimulate ... industry.      (Logo: http://photos.prnewswire.com/prnh/20150416/739742-a) ,     ...
(Date:4/16/2015)... , April 16, 2015  AnaptysBio, Inc., a ... therapeutic antibodies, today announced the advancement of ... into IND-enabling studies. The Company,s anti-IL-36R therapeutic ... for generalized pustular psoriasis (GPP), an orphan ... need. ANB019 is wholly owned within AnaptysBio,s proprietary ...
(Date:4/16/2015)... , April 16, 2015 Avelas Biosciences, an ... improving cancer surgeries, announced today that it has initiated ... illuminator, AVB-620, in women with primary, non-recurrent breast cancer ... also welcomed the addition of Steven Chen , ... The open label, dose escalation study will enroll up ...
(Date:4/16/2015)... LAUSANNE , Switzerland ... Debiopharm International SA (Debiopharm), part of Debiopharm Group ™ ... prescription drugs that target unmet medical needs ... that preclinical data on the investigational compounds ... inhibitor) will be presented at the 2015 ...
Breaking Biology Technology:Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
Cached News: